177 related articles for article (PubMed ID: 21352291)
41. [Delayed diagnosis of hydroa vacciniforme-like lymphoproliferative disorder in a patient with skin rashes].
Umeki Y; Ikeda M; Nakahara W; Asako M; Matsuoka Y; Terakawa T; Matsunaga H; Tadokoro R; Sekiguchi M; Matsui T; Oka K; Higuchi K; Sawada A; Inoue M; Ueda S
Rinsho Ketsueki; 2023; 64(3):209-213. PubMed ID: 37019675
[TBL] [Abstract][Full Text] [Related]
42. Hydroa vacciniforme in an adolescent girl.
Raza N; Bari AU; Farooq M
J Coll Physicians Surg Pak; 2007 Jun; 17(6):359-61. PubMed ID: 17623588
[TBL] [Abstract][Full Text] [Related]
43. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
[TBL] [Abstract][Full Text] [Related]
44. Hydroa vacciniforme with ocular involvement.
Wisuthsarewong W; Leenutaphong V; Viravan S
J Med Assoc Thai; 1998 Oct; 81(10):807-11. PubMed ID: 9803075
[TBL] [Abstract][Full Text] [Related]
45. Hydroa vacciniforme-like lymphoproliferative disorder in Ecuadorian children: A case series.
Garzón E; Dávila-Rodríguez JJ
Indian J Dermatol Venereol Leprol; 2023; 89(3):403-407. PubMed ID: 33871198
[TBL] [Abstract][Full Text] [Related]
46. [Bazin's hydroa vacciniforme. General review of 2 cases].
Aubin F; Manteaux A; Blanc D; Courtot F; Humbert P; Agache P
Pediatrie; 1990; 45(11):775-80. PubMed ID: 2177880
[TBL] [Abstract][Full Text] [Related]
47. An elderly patient with chronic active Epstein-Barr virus infection with severe hydroa vacciniforme-like eruptions associated with αβT-cell proliferation.
Nomura H; Egami S; Kasai H; Mori M; Yokoyama T; Fujimoto A; Sugiura M; Iwatsuki K
J Dermatol; 2014 Apr; 41(4):360-2. PubMed ID: 24628134
[No Abstract] [Full Text] [Related]
48. Clinicoprognostic Study of Hydroa Vacciniforme-like Lymphoproliferative Diseases: A Systematic Review.
Kim YJ; Yang HJ; Won CH; Chang SE; Lee MW; Lee WJ
Dermatology; 2023; 239(5):700-711. PubMed ID: 37231869
[TBL] [Abstract][Full Text] [Related]
49. Hydroa vacciniforme-like lymphoma of an adult: a case report with review of the literature.
Wang M; Wang S; Yang QP; Liu YM; Gao LM; Sun H; Liu WP
Diagn Pathol; 2013 May; 8():72. PubMed ID: 23635342
[TBL] [Abstract][Full Text] [Related]
50. Phenotypic analysis in a case of hydroa vacciniforme-like eruptions associated with chronic active Epstein-Barr virus disease of γδ T cells.
Tanaka C; Hasegawa M; Fujimoto M; Iwatsuki K; Yamamoto T; Yamada K; Kawa K; Saikawa Y; Toga A; Mase S; Wada T; Takehara K; Yachie A
Br J Dermatol; 2012 Jan; 166(1):216-8. PubMed ID: 21729029
[No Abstract] [Full Text] [Related]
51. A case of hydroa vacciniforme with unusual ear mutilation.
Kim WS; Yeo UC; Chun HS; Lee ES
Clin Exp Dermatol; 1998 Mar; 23(2):70-2. PubMed ID: 9692309
[TBL] [Abstract][Full Text] [Related]
52. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
[TBL] [Abstract][Full Text] [Related]
53. Hydroa vacciniforme: diagnosis and therapy.
Goldgeier MH; Nordlund JJ; Lucky AW; Sibrack LA; McCarthy MJ; McGuire J
Arch Dermatol; 1982 Aug; 118(8):588-91. PubMed ID: 7103528
[TBL] [Abstract][Full Text] [Related]
54. Primary cutaneous hydroa vacciniforme-like lymphoma with indolent clinical course: report of two cases and review of literature.
Li Y; Chen XH; Tian XY; Li B; Li Z
Int J Surg Pathol; 2013 Apr; 21(2):161-8. PubMed ID: 22807582
[TBL] [Abstract][Full Text] [Related]
55. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
Touge C; Agawa H; Sairenji T; Inoue Y
Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
[TBL] [Abstract][Full Text] [Related]
56. [Cutaneous and neurologic vasculitis disclosing EBV-selective immunodeficiency].
Grosieux C; Amoric JC; Mechinaud F; Moreau A; Mussini JM; Fesneau H; Dreno B; Bureau B; Stalder JF; Litoux P
Ann Dermatol Venereol; 1996; 123(6-7):387-92. PubMed ID: 8959062
[TBL] [Abstract][Full Text] [Related]
57. Primary cutaneous Epstein-Barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical course.
Park S; Lee DY; Kim WS; Ko YH
Am J Dermatopathol; 2010 Dec; 32(8):832-6. PubMed ID: 20595887
[TBL] [Abstract][Full Text] [Related]
58. Hydroa vacciniforme-like lymphoproliferative disorder (HV-LPD) is an Epstein-Barr virus (EBV) associated disease.
Ordoñez-Parra J; Mejía Cortes M; Tamayo-Buendía MM; Infante Gómez AM
An Bras Dermatol; 2021; 96(3):388-390. PubMed ID: 33849755
[No Abstract] [Full Text] [Related]
59. [Experimental induction of skin manifestations in hydroa vacciniforme].
Galosi A; Plewig G; Ring J; Meurer M; Schmoeckel C; Schurig V; Dorn M
Hautarzt; 1985 Oct; 36(10):566-72. PubMed ID: 4066317
[TBL] [Abstract][Full Text] [Related]
60. Factors influencing the photo-reproduction of hydroa vacciniforme lesions.
Leroy D; Dompmartin A; Michel M; Tack B; Bravard P; Louvet S
Photodermatol Photoimmunol Photomed; 1997 Jun; 13(3):98-102. PubMed ID: 9372526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
